China · Delayed Price · Currency is CNY Boji Medical Technology Statistics
Total Valuation
SHE:300404 has a market cap or net worth of CNY 3.71 billion. The enterprise value is 3.39 billion.
| Market Cap | 3.71B |
| Enterprise Value | 3.39B |
Important Dates
The next estimated earnings date is Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | Jul 15, 2025 |
Share Statistics
SHE:300404 has 383.20 million shares outstanding. The number of shares has increased by 0.38% in one year.
| Current Share Class | 383.20M |
| Shares Outstanding | 383.20M |
| Shares Change (YoY) | +0.38% |
| Shares Change (QoQ) | -0.54% |
| Owned by Insiders (%) | 34.43% |
| Owned by Institutions (%) | 2.01% |
| Float | 246.03M |
Valuation Ratios
The trailing PE ratio is 86.28.
| PE Ratio | 86.28 |
| Forward PE | n/a |
| PS Ratio | 3.90 |
| PB Ratio | 3.36 |
| P/TBV Ratio | 3.65 |
| P/FCF Ratio | 75.32 |
| P/OCF Ratio | 55.26 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 58.03, with an EV/FCF ratio of 68.85.
| EV / Earnings | 78.68 |
| EV / Sales | 3.57 |
| EV / EBITDA | 58.03 |
| EV / EBIT | 111.22 |
| EV / FCF | 68.85 |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.92 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.72 |
| Debt / FCF | 0.85 |
| Interest Coverage | 20.62 |
Financial Efficiency
Return on equity (ROE) is 4.19% and return on invested capital (ROIC) is 4.00%.
| Return on Equity (ROE) | 4.19% |
| Return on Assets (ROA) | 1.20% |
| Return on Invested Capital (ROIC) | 4.00% |
| Return on Capital Employed (ROCE) | 2.66% |
| Weighted Average Cost of Capital (WACC) | 5.57% |
| Revenue Per Employee | 792,938 |
| Profits Per Employee | 35,939 |
| Employee Count | 1,198 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 3.06 |
Taxes
In the past 12 months, SHE:300404 has paid 1.59 million in taxes.
| Income Tax | 1.59M |
| Effective Tax Rate | 3.47% |
Stock Price Statistics
The stock price has increased by +15.61% in the last 52 weeks. The beta is 0.24, so SHE:300404's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +15.61% |
| 50-Day Moving Average | 10.29 |
| 200-Day Moving Average | 10.36 |
| Relative Strength Index (RSI) | 37.90 |
| Average Volume (20 Days) | 12,489,032 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300404 had revenue of CNY 949.94 million and earned 43.05 million in profits. Earnings per share was 0.11.
| Revenue | 949.94M |
| Gross Profit | 252.37M |
| Operating Income | 30.46M |
| Pretax Income | 45.89M |
| Net Income | 43.05M |
| EBITDA | 56.39M |
| EBIT | 30.46M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
The company has 393.85 million in cash and 41.91 million in debt, with a net cash position of 351.94 million or 0.92 per share.
| Cash & Cash Equivalents | 393.85M |
| Total Debt | 41.91M |
| Net Cash | 351.94M |
| Net Cash Per Share | 0.92 |
| Equity (Book Value) | 1.10B |
| Book Value Per Share | 2.79 |
| Working Capital | 484.56M |
Cash Flow
In the last 12 months, operating cash flow was 67.05 million and capital expenditures -17.85 million, giving a free cash flow of 49.20 million.
| Operating Cash Flow | 67.05M |
| Capital Expenditures | -17.85M |
| Depreciation & Amortization | 25.94M |
| Net Borrowing | -4.54M |
| Free Cash Flow | 49.20M |
| FCF Per Share | 0.13 |
Margins
Gross margin is 26.57%, with operating and profit margins of 3.21% and 4.53%.
| Gross Margin | 26.57% |
| Operating Margin | 3.21% |
| Pretax Margin | 4.83% |
| Profit Margin | 4.53% |
| EBITDA Margin | 5.94% |
| EBIT Margin | 3.21% |
| FCF Margin | 5.18% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.13%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.13% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 13.54% |
| Buyback Yield | -0.38% |
| Shareholder Yield | -0.25% |
| Earnings Yield | 1.16% |
| FCF Yield | 1.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 2, 2022. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 2, 2022 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
SHE:300404 has an Altman Z-Score of 5.22 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.22 |
| Piotroski F-Score | 6 |